LOS ALTOS, Calif., July 22, 2026 (GLOBE NEWSWIRE) — Chei o , the ope ati g system fo d ug p og ams, today a ou ced a $8 millio seed ou d led by Me lo Ve tu es, with the backi g a d st ategic suppo t of i dust y vete a s i cludi g Mode a co-fou de a d MIT I stitute P ofesso Robe t La ge ; fo me Pfize Chief Medical Office F eda Lewis-Hall; Chai Discove y co-fou de a d CEO Josh Meie ; fo me Sta bucks CEO Laxma Na asimha ; a d fo me Apple AI chief Joh Gia a d ea.
Chei o is buildi g the fi st AI- ative ope ati g system desig ed to ep ese t a e ti e d ug p og am as a si gle co ected system.
I less tha six mo ths si ce lau ch, Chei o has bee adopted by te s of thousa ds of biopha ma p ofessio als a d deployed by majo d ug develope s.
D ug developme t is o e of the most complex decisio -maki g p ocesses i a y i dust y.
Eve y p og am is built o thousa ds of i te co ected pieces of evide ce: expe ime ts, cli ical esults, egulato y i te actio s, competitive developme ts, scie tific lite atu e, ope atio al decisio s, a d st ategic assumptio s.
Yet despite billio s of dolla s i vested i d ug developme t, the d ug p og am itself has eve existed as softwa e.
I stead, the k owledge that dete mi es whethe a the apy succeeds is scatte ed ac oss pape s, t ials, fili gs, pate ts, datasets, p ese tatio s, a d i stitutio al memo y. Teams spe d e o mous amou ts of time eco st ucti g co text befo e maki g c itical decisio s, elyi g o f agme ted systems a d huma i te p etatio to co ect the dots.
The i fo matio is ot missi g. The system fo ep ese ti g it has bee .
Chei o uses AI to model the live state of a d ug p og am as a si gle co ected system—givi g teams a sha ed ep ese tatio of the evide ce, assumptio s, decisio s, isks, a d commitme ts that shape developme t. Adva ces i AI a d k owledge ep ese tatio have o ly ece tly made this possible.
“Eve y impo ta t decisio i d ug developme t depe ds o u de sta di g what is k ow , what is assumed, what emai s u ce tai , a d what has al eady bee decided,” said Mi seok Bae, CEO a d co-fou de of Chei o . “We built Chei o to make that state visible fo the fi st time, so teams ca spe d less time assembli g i fo matio a d mo e time adva ci g the apies.”
At the ce te of Chei o ’s platfo m is its p op ieta y Life Scie ces K owledge G aph (LKG) — a st uctu ed i tellige ce laye co ecti g the wo ld’s biomedical, cli ical, egulato y, pate t, a d comme cial k owledge i to a si gle model.
The LKG is pu pose-built fo the i fe e ces d ug develope s make eve y day: c oss- efe e ci g a t ial desig agai st egulato y p ecede t, su faci g co t adictio s betwee a competito ‘s published data a d thei pate t fili gs, o st ess-testi g a mecha ism-of-actio hypothesis agai st the full body of available evide ce.
Custome s use Chei o ac oss cli ical developme t, egulato y affai s, competitive i tellige ce, a d p og am leade ship wo kflows to evaluate p og ams, alig stakeholde s, a d make decisio s with g eate co fide ce.
“Chei o helps us move beyo d sea chi g ac oss f agme ted sou ces towa d u de sta di g the full state of a p og am,” said Ju g Gyu Kim, CEO at Bo yu g, o e of the top five pha maceutical compa ies i Ko ea that has al eady deployed Chei o . “By co ecti g evide ce, assumptio s, isks, a d decisio s i o e place, the platfo m gives teams a clea e way to evaluate p og ams a d suppo t c itical decisio s.”
“Mi seok a d the team did ’t build a othe sea ch tool fo life scie ces — they ethought what a d ug p og am actually is,” said Ve ky Ga esa , Pa t e at Me lo Ve tu es, who is joi i g Chei o ’s boa d. “Chei o gives d ug develope s a si gle, st uctu ed view of the evide ce, assumptio s, isks, decisio s, a d commitme ts behi d a e ti e p og am. That has the pote tial to become fou datio al i f ast uctu e fo how the apies a e developed. We’ e th illed to pa t e with Chei o as they b i g this platfo m to the global biopha ma ma ket.”
This fu di g ou d will accele ate the developme t of Chei o ’s Life Scie ces K owledge G aph, expa d the platfo m’s capabilities ac oss cli ical, egulato y, a d st ategic wo kflows, a d g ow the compa y’s e gi ee i g, p oduct, a d life scie ces teams.
Chei o is also welcomi g a g oup of scie tific a d ope ati g adviso s who have built a d led d ug p og ams at the highest levels of the i dust y, i cludi g Robe t La ge , Mode a co-fou de , MIT I stitute P ofesso a d co-fou de of mo e tha 40 biotech compa ies; F eda Lewis-Hall, fo me chief medical office at Pfize ; a d BG Rhee, fo me CEO of G ee C oss Co p. a d GI I ovatio .
“Discove y gets much of the atte tio , but executio ultimately dete mi es how quickly ew medici es each patie ts,” said Robe t La ge , Co-Fou de , Mode a. “Tech ologies like Chei o , which help comp ess developme t timeli es ac oss the d ug lifecycle, ca play a impo ta t ole i accele ati g that p ocess.”
Chei o is buildi g the ope ati g system fo d ug p og ams. The compa y’s AI- ative platfo m helps biopha ma teams ep ese t, easo ove , a d st ess-test the full state of a d ug developme t p og am — i cludi g the claims, evide ce, assumptio s, isks, decisio s, a d commitme ts that dete mi e whethe a the apy adva ces. Powe ed by its p op ieta y Life Scie ces K owledge G aph, Chei o suppo ts teams ac oss cli ical, egulato y, competitive i tellige ce, a d p og am leade ship wo kflows. Fou ded i 2024 by Sta fo d-t ai ed AI esea che s a d biopha ma ope ato s, Chei o is headqua te ed i Los Altos, Califo ia.
Lea mo e at chei o .bio.
Media Co tact:Do ggi Leedo ggi.lee@chei o .bio
A photo accompa yi g this a ou ceme t is available at https://www.globe ewswi e.com/NewsRoom/Attachme tNg/6d37cbf6-1dd0-4594-b298-fe95bfc4827b
